Publication Date
| In 2025 | 0 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 3 |
| Since 2016 (last 10 years) | 6 |
| Since 2006 (last 20 years) | 6 |
Descriptor
| Comparative Analysis | 6 |
| Research Problems | 6 |
| Medical Research | 5 |
| Risk | 5 |
| Meta Analysis | 4 |
| Models | 3 |
| Randomized Controlled Trials | 3 |
| Bias | 2 |
| Classification | 2 |
| Epidemiology | 2 |
| Evidence | 2 |
| More ▼ | |
Source
| Research Synthesis Methods | 6 |
Author
| Hróbjartsson, Asbjørn | 2 |
| Savovic, Jelena | 2 |
| Abdi, Suhayb | 1 |
| Carpenter, J. R. | 1 |
| Chang Xu | 1 |
| Clayton, Gemma | 1 |
| Clayton, Gemma L. | 1 |
| Efthimiou, Orestis | 1 |
| Fisher, D. | 1 |
| Freeman, S. C. | 1 |
| Gelle, Mustafe Hassan Adan | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 6 |
| Reports - Evaluative | 2 |
| Reports - Research | 2 |
| Information Analyses | 1 |
| Reports - Descriptive | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkYuan Tian; Xi Yang; Suhail A. Doi; Luis Furuya-Kanamori; Lifeng Lin; Joey S. W. Kwong; Chang Xu – Research Synthesis Methods, 2024
RobotReviewer is a tool for automatically assessing the risk of bias in randomized controlled trials, but there is limited evidence of its reliability. We evaluated the agreement between RobotReviewer and humans regarding the risk of bias assessment based on 1955 randomized controlled trials. The risk of bias in these trials was assessed via two…
Descriptors: Risk, Randomized Controlled Trials, Classification, Robotics
Efthimiou, Orestis; White, Ian R. – Research Synthesis Methods, 2020
Standard models for network meta-analysis simultaneously estimate multiple relative treatment effects. In practice, after estimation, these multiple estimates usually pass through a formal or informal selection procedure, eg, when researchers draw conclusions about the effects of the best performing treatment in the network. In this paper, we…
Descriptors: Models, Meta Analysis, Network Analysis, Simulation
Nejstgaard, Camilla Hansen; Lundh, Andreas; Abdi, Suhayb; Clayton, Gemma; Gelle, Mustafe Hassan Adan; Laursen, David Ruben Teindl; Olorisade, Babatunde Kazeem; Savovic, Jelena; Hróbjartsson, Asbjørn – Research Synthesis Methods, 2022
Randomised trials are often funded by commercial companies and methodological studies support a widely held suspicion that commercial funding may influence trial results and conclusions. However, these studies often have a risk of confounding and reporting bias. The risk of confounding is markedly reduced in meta-epidemiological studies that…
Descriptors: Medical Research, Randomized Controlled Trials, Corporations, Financial Support
Wang, Qianying; Liao, Jing; Lapata, Mirella; Macleod, Malcolm – Research Synthesis Methods, 2022
We sought to apply natural language processing to the task of automatic risk of bias assessment in preclinical literature, which could speed the process of systematic review, provide information to guide research improvement activity, and support translation from preclinical to clinical research. We use 7840 full-text publications describing…
Descriptors: Risk, Natural Language Processing, Medical Research, Networks
Moustgaard, Helene; Jones, Hayley E.; Savovic, Jelena; Clayton, Gemma L.; Sterne, Jonathan AC; Higgins, Julian PT; Hróbjartsson, Asbjørn – Research Synthesis Methods, 2020
Randomized clinical trials underpin evidence-based clinical practice, but flaws in their conduct may lead to biased estimates of intervention effects and hence invalid treatment recommendations. The main approach to the empirical study of bias is to collate a number of meta-analyses and, within each, compare the results of trials with and without…
Descriptors: Epidemiology, Evidence, Medical Research, Intervention
Freeman, S. C.; Fisher, D.; Tierney, J. F.; Carpenter, J. R. – Research Synthesis Methods, 2018
Background: Stratified medicine seeks to identify patients most likely to respond to treatment. Individual participant data (IPD) network meta-analysis (NMA) models have greater power than individual trials to identify treatment-covariate interactions (TCIs). Treatment-covariate interactions contain "within" and "across" trial…
Descriptors: Medical Research, Patients, Outcomes of Treatment, Meta Analysis
